BloodPressureHeartMeds.Net

Regeneron announces additional data from aflibercept Phase 3 trial on colorectal cancer

August 14, 2017

"We must emphasise the role of the scientist in measuring the success of the UN objectives. We have to work harder to collect data and improve monitoring and surveillance so that what gets done to reduce NCDs gets measured. We need to have the right methods, the right tools to do this, through academic science and methodology. Scientific and medical societies are best placed to do this and we must engage in this process", says Marc Decramer, President of the European Respiratory Society, an ECDA member.

A more ambitious approach was favoured by Members of the European Parliament last week, with the vote of a motion for a resolution that calls for the urgent adoption of NCDs prevention measures across Europe.

We will continue our efforts to promote a Europe less vulnerable to chronic diseases and to disseminate our policy recommendations, much of them only requiring simple and cheap changes with substantial impact on the diseases burden.

Source: European Society of Cardiology